CAFFEINE PHENOTYPING OF CYTOCHROME P4501A2, N-ACETYLTRANSFERASE, AND XANTHINE-OXIDASE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS

被引:23
作者
SPIGELMAN, AD
FARMER, KCR
OLIVER, S
NUGENT, KP
BENNETT, PN
NOTARIANNI, LJ
DOBROCKY, P
PHILLIPS, RKS
机构
[1] ST MARYS HOSP,SCH MED,ACAD SURG UNIT,LONDON,ENGLAND
[2] UNIV BATH,POSTGRAD MED SCH,BATH BA2 7AY,AVON,ENGLAND
关键词
FAMILIAL POLYPOSIS SYNDROME; DUODENAL NEOPLASMS; CARCINOGENS; COLORECTAL NEOPLASMS; BILE; ADENOMA;
D O I
10.1136/gut.36.2.251
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with familial adenomatous polyposis (FAP) and age and sex matched controls were tested for cytochrome P4501A2 (CYP1A2), N-acetyltransferase, and xanthine oxidase activities using caffeine urinary metabolites as a discriminator. FAP patients showed significant underactivity of N-acetyltransferase (which inactivates some carcinogens) and significant overactivity of CYP1A2 (which activates some carcinogens). Xanthine oxidase activity, which can generate free radicals and cause cellular damage, was significantly increased in the FAP patients. All but one of the FAP patients had undergone colectomy. A separate group of six patients was therefore assessed before and at an average time of eight weeks after colectomy. No effect on enzyme activity was seen. The differences in enzyme activities detected in this study could produce an excess of active carcinogenic metabolites in the bile of FAP patients and contribute to the high risk for intestinal cancer in FAP.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 29 条
[1]  
BETT KF, 1987, CANCER RES, V47, P1466
[2]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[3]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[4]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[5]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[6]   VARIABILITY IN CAFFEINE METABOLISM [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (05) :591-602
[7]   ACETYLATOR GENOTYPE AND ARYLAMINE-INDUCED CARCINOGENESIS [J].
HEIN, DW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :37-66
[8]   IS ENVIRONMENTAL CARCINOGENESIS MODULATED BY HOST POLYMORPHISM [J].
IDLE, JR .
MUTATION RESEARCH, 1991, 247 (02) :259-266
[9]   USE OF CAFFEINE METABOLITE RATIOS TO EXPLORE CYP1A2 AND XANTHINE-OXIDASE ACTIVITIES [J].
KALOW, W ;
TANG, BK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :508-519
[10]  
KIRLIN WG, 1991, CANCER RES, V51, P549